Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Lheureux

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 18, 2023
Gestational trophoblastic neoplasia: does centralization of care impact clinical management?Cristina Mitric, Kelsey Yang, Gita Bhat, et al.
Seminars in Cancer Biology|April 8, 2022
Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironmentEsther Schoutrop, Lidia Moyano-Galceran, Stephanie Lheureux, et al.
Gynecologic Oncology|February 6, 2021
The use of bevacizumab in the modern era of targeted therapy for ovarian cancer: A systematic review and meta-analysisShiru Liu, Lawrence Kasherman, Rouhi Fazelzad, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 11, 2025
Safety of antibody-drug conjugates in gynecologic cancers: current evidence and management approachesEsteban A Ciliberti, Francisco Javier Calleja-Holgado, Stephanie Lheureux, et al.
Gynecologic Oncology|May 16, 2023
Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancerSabrina Piedimonte, Rachel Kim, Marcus Q Bernardini, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 4, 2024
HER2-low and Overexpression in Mucinous Ovarian Cancer: Analysis of ASCO/CAP and ToGA Immunohistochemical ScoringRachel Han, Ainhoa Madariaga, Eduardo Gonzalez-Ochoa, et al.
Current Oncology (Toronto, Ont.)|August 25, 2022
Patterns of First-Line Systemic Therapy Delivery and Outcomes in Advanced Epithelial Ovarian Cancer in OntarioShiru L Liu, Wing C Chan, Geneviève Bouchard-Fortier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2024
Genomic Landscape of ctDNA and Real-World Outcomes in Advanced Endometrial CancerPamela Soberanis Pina, Keelia Clemens, Adrian Bubie, et al.
Cancer|February 26, 2020
Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancerYeh Chen Lee, Lisa Wang, Elise C Kohn, et al.
Expert Opinion on Biological Therapy|June 23, 2017
Updates and current challenges in microRNA research for personalized medicine in ovarian cancerVictoria Mandilaras, Mégane Vernon, Matthieu Meryet-Figuière, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 18, 2023
Gestational trophoblastic neoplasia: does centralization of care impact clinical management?Cristina Mitric, Kelsey Yang, Gita Bhat, et al.
Seminars in Cancer Biology|April 8, 2022
Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironmentEsther Schoutrop, Lidia Moyano-Galceran, Stephanie Lheureux, et al.
Gynecologic Oncology|February 6, 2021
The use of bevacizumab in the modern era of targeted therapy for ovarian cancer: A systematic review and meta-analysisShiru Liu, Lawrence Kasherman, Rouhi Fazelzad, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 11, 2025
Safety of antibody-drug conjugates in gynecologic cancers: current evidence and management approachesEsteban A Ciliberti, Francisco Javier Calleja-Holgado, Stephanie Lheureux, et al.
Gynecologic Oncology|May 16, 2023
Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancerSabrina Piedimonte, Rachel Kim, Marcus Q Bernardini, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 4, 2024
HER2-low and Overexpression in Mucinous Ovarian Cancer: Analysis of ASCO/CAP and ToGA Immunohistochemical ScoringRachel Han, Ainhoa Madariaga, Eduardo Gonzalez-Ochoa, et al.
Current Oncology (Toronto, Ont.)|August 25, 2022
Patterns of First-Line Systemic Therapy Delivery and Outcomes in Advanced Epithelial Ovarian Cancer in OntarioShiru L Liu, Wing C Chan, Geneviève Bouchard-Fortier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2024
Genomic Landscape of ctDNA and Real-World Outcomes in Advanced Endometrial CancerPamela Soberanis Pina, Keelia Clemens, Adrian Bubie, et al.
Cancer|February 26, 2020
Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancerYeh Chen Lee, Lisa Wang, Elise C Kohn, et al.
Expert Opinion on Biological Therapy|June 23, 2017
Updates and current challenges in microRNA research for personalized medicine in ovarian cancerVictoria Mandilaras, Mégane Vernon, Matthieu Meryet-Figuière, et al.
Pageof 15